List of Tables

Table 1. Aminoglycoside Drug Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Aminoglycoside Drug Market Restraints

Table 3. Aminoglycoside Drug Market Trends

Table 4. Aminoglycoside Drug Industry Policy

Table 5. Global Aminoglycoside Drug Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Aminoglycoside Drug Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Aminoglycoside Drug Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Aminoglycoside Drug Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Aminoglycoside Drug Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Aminoglycoside Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Aminoglycoside Drug Mergers & Acquisitions, Expansion Plans

Table 12. Global Aminoglycoside Drug Manufacturers Product Type

Table 13. Head Office and Aminoglycoside Drug Production Site of Key Manufacturer

Table 14. Aminoglycoside Drug Capacity of Major Manufacturers and Future Plan

Table 15. China Aminoglycoside Drug Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Aminoglycoside Drug Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Aminoglycoside Drug Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Aminoglycoside Drug Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Aminoglycoside Drug Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Aminoglycoside Drug Production by Region, 2020-2025, (K Units)

Table 21. Global Aminoglycoside Drug Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Aminoglycoside Drug Upstream (Raw Materials)

Table 23. Global Aminoglycoside Drug Typical Customers

Table 24. Aminoglycoside Drug Typical Distributors

Table 25. by Type, Global Aminoglycoside Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Aminoglycoside Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Aminoglycoside Drug Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Aminoglycoside Drug Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Aminoglycoside Drug Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Aminoglycoside Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Aminoglycoside Drug Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Aminoglycoside Drug Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Aminoglycoside Drug Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Aminoglycoside Drug Sales Quantity Market Share, 2020-2031

Table 35. Jemicare Company Information, Head Office, Market Area, and Industry Position

Table 36. Jemicare Aminoglycoside Drug Models, Specifications, and Application

Table 37. Jemicare Aminoglycoside Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. Jemicare Company Profile and Main Business

Table 39. Jemicare Recent Developments

Table 40. Teva Company Information, Head Office, Market Area, and Industry Position

Table 41. Teva Aminoglycoside Drug Models, Specifications, and Application

Table 42. Teva Aminoglycoside Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. Teva Company Profile and Main Business

Table 44. Teva Recent Developments

Table 45. Novartis Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 46. Novartis Pharmaceuticals Aminoglycoside Drug Models, Specifications, and Application

Table 47. Novartis Pharmaceuticals Aminoglycoside Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Novartis Pharmaceuticals Company Profile and Main Business

Table 49. Novartis Pharmaceuticals Recent Developments

Table 50. Fangyuan-pharma Company Information, Head Office, Market Area, and Industry Position

Table 51. Fangyuan-pharma Aminoglycoside Drug Models, Specifications, and Application

Table 52. Fangyuan-pharma Aminoglycoside Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. Fangyuan-pharma Company Profile and Main Business

Table 54. Fangyuan-pharma Recent Developments

Table 55. Aike Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 56. Aike Pharmaceutical Aminoglycoside Drug Models, Specifications, and Application

Table 57. Aike Pharmaceutical Aminoglycoside Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. Aike Pharmaceutical Company Profile and Main Business

Table 59. Aike Pharmaceutical Recent Developments

Table 60. Cipla Company Information, Head Office, Market Area, and Industry Position

Table 61. Cipla Aminoglycoside Drug Models, Specifications, and Application

Table 62. Cipla Aminoglycoside Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 63. Cipla Company Profile and Main Business

Table 64. Cipla Recent Developments

Table 65. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 66. Pfizer Aminoglycoside Drug Models, Specifications, and Application

Table 67. Pfizer Aminoglycoside Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 68. Pfizer Company Profile and Main Business

Table 69. Pfizer Recent Developments

Table 70. FRESENIUS KABI Company Information, Head Office, Market Area, and Industry Position

Table 71. FRESENIUS KABI Aminoglycoside Drug Models, Specifications, and Application

Table 72. FRESENIUS KABI Aminoglycoside Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 73. FRESENIUS KABI Company Profile and Main Business

Table 74. FRESENIUS KABI Recent Developments

Table 75. Sun Pharma Company Information, Head Office, Market Area, and Industry Position

Table 76. Sun Pharma Aminoglycoside Drug Models, Specifications, and Application

Table 77. Sun Pharma Aminoglycoside Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 78. Sun Pharma Company Profile and Main Business

Table 79. Sun Pharma Recent Developments

Table 80. Hikma Company Information, Head Office, Market Area, and Industry Position

Table 81. Hikma Aminoglycoside Drug Models, Specifications, and Application

Table 82. Hikma Aminoglycoside Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 83. Hikma Company Profile and Main Business

Table 84. Hikma Recent Developments

Table 85. Lannett Company Company Information, Head Office, Market Area, and Industry Position

Table 86. Lannett Company Aminoglycoside Drug Models, Specifications, and Application

Table 87. Lannett Company Aminoglycoside Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 88. Lannett Company Company Profile and Main Business

Table 89. Lannett Company Recent Developments

List of Figures

Figure 1. Aminoglycoside Drug Picture

Figure 2. Global Aminoglycoside Drug Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Aminoglycoside Drug Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Aminoglycoside Drug Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Aminoglycoside Drug Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Aminoglycoside Drug Sales Quantity (K Units) & (2020-2031)

Figure 7. China Aminoglycoside Drug Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Aminoglycoside Drug Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Aminoglycoside Drug Market Share of Global, 2020-2031

Figure 10. Global Aminoglycoside Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Aminoglycoside Drug Key Participants, Market Share, 2024

Figure 12. Global Aminoglycoside Drug Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Aminoglycoside Drug Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Aminoglycoside Drug Production Market Share & Forecast by Region, 2020-2031

Figure 15. Aminoglycoside Drug Industry Chain

Figure 16. Aminoglycoside Drug Procurement Model

Figure 17. Aminoglycoside Drug Sales Model

Figure 18. Aminoglycoside Drug Sales Channels, Direct Sales, and Distribution

Figure 19. Neomycin

Figure 20. Tobramycin

Figure 21. Gentamicin

Figure 22. Amikacin

Figure 23. Etimicin

Figure 24. Others

Figure 25. by Type, Global Aminoglycoside Drug Consumption Value, 2020-2031, US$ Million

Figure 26. by Type, Global Aminoglycoside Drug Consumption Value Market Share, 2020-2031

Figure 27. by Type, Global Aminoglycoside Drug Sales Quantity, 2020-2031, (K Units)

Figure 28. by Type, Global Aminoglycoside Drug Sales Quantity Market Share, 2020-2031

Figure 29. by Type, Global Aminoglycoside Drug Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 30. Hospital

Figure 31. Retail Pharmacy

Figure 32. Others

Figure 33. by Application, Global Aminoglycoside Drug Consumption Value, 2020-2031, US$ Million

Figure 34. by Application, Global Aminoglycoside Drug Revenue Market Share, 2020-2031

Figure 35. by Application, Global Aminoglycoside Drug Sales Quantity, 2020-2031, (K Units)

Figure 36. by Application, Global Aminoglycoside Drug Sales Quantity Market Share, 2020-2031

Figure 37. by Application, Global Aminoglycoside Drug Price, 2020-2031, (US$/Unit)

Figure 38. By Region, Global Aminoglycoside Drug Consumption Value Market Share, 2020-2031

Figure 39. By Region, Global Aminoglycoside Drug Sales Quantity Market Share, 2020-2031

Figure 40. North America Aminoglycoside Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 41. By Country, North America Aminoglycoside Drug Consumption Value Market Share, 2024

Figure 42. Europe Aminoglycoside Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 43. By Country, Europe Aminoglycoside Drug Consumption Value Market Share, 2024

Figure 44. Asia Pacific Aminoglycoside Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 45. By Country/Region, Asia Pacific Aminoglycoside Drug Consumption Value Market Share, 2024

Figure 46. South America Aminoglycoside Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 47. By Country, South America Aminoglycoside Drug Consumption Value Market Share, 2024

Figure 48. Middle East & Africa Aminoglycoside Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 49. United States Aminoglycoside Drug Sales Quantity, 2020-2031, (K Units)

Figure 50. by Type, United States Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 51. by Application, United States Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 52. Europe Aminoglycoside Drug Sales Quantity, 2020-2031, (K Units)

Figure 53. by Type, Europe Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 54. by Application, Europe Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 55. China Aminoglycoside Drug Sales Quantity, 2020-2031, (K Units)

Figure 56. by Type, China Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 57. by Application, China Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 58. Japan Aminoglycoside Drug Sales Quantity, 2020-2031, (K Units)

Figure 59. by Type, Japan Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 60. by Application, Japan Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 61. South Korea Aminoglycoside Drug Sales Quantity, 2020-2031, (K Units)

Figure 62. by Type, South Korea Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 63. by Application, South Korea Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 64. Southeast Asia Aminoglycoside Drug Sales Quantity, 2020-2031, (K Units)

Figure 65. by Type, Southeast Asia Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 66. by Application, Southeast Asia Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 67. India Aminoglycoside Drug Sales Quantity, 2020-2031, (K Units)

Figure 68. by Type, India Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 69. by Application, India Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 70. Middle East & Africa Aminoglycoside Drug Sales Quantity, 2020-2031, (K Units)

Figure 71. by Type, Middle East & Africa Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 72. by Application, Middle East & Africa Aminoglycoside Drug Sales Quantity Market Share, 2024 VS 2031

Figure 73. Research Methodology

Figure 74. Breakdown of Primary Interviews

Figure 75. Bottom-up Approaches

Figure 76. Top-down Approaches